Effect of antihypertensive deprescribing on hospitalisation and mortality: long-term follow-up of the OPTiMISE randomised controlled trial (Lancet Healthy Longevity, 2024)

(untitled) - Sheppard, JP; Temple, E; Wang, A; Smith, A; Pollock, S; Ford, GA; Hobbs, FDR; Kenealy, N; Little, P; Lown, M; de Lusignan, S; Mant, J; et al.